Advisory Services Network, LLC

Position in RPRX — Royalty Pharma plc

CIK 1573876 Atlanta, GA

Position in RPRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,624,023

+$362,621 QoQ

Shares Held

33,855

+3.7% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Advisory Services Network, LLC holds $24,652,024 across 161 Biotechnology names. RPRX ranks #5 (6.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	51,990	$4,893,296
2	REGN	Regeneron Pharmaceuticals, Inc.	3,953	$3,054,242
3	VRTX	Vertex Pharmaceuticals Inc / Ma	5,218	$2,330,040
4	ALNY	Alnylam Pharmaceuticals, Inc.	6,314	$2,089,107
5	RPRX	Royalty Pharma plc This page	33,855	$1,624,023
6	EXEL	Exelixis, Inc.	29,442	$1,262,766
7	OCUL	Ocular Therapeutix, Inc	138,897	$1,176,456
8	WVE	Wave Life Sciences Ltd.	144,950	$1,050,887

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,624,023	33,855	+3.7%	Shares	Sole	2026-05-15
2025-12-31	$1,261,402	32,645	+117.6%	Shares	Sole	2026-02-17
2025-09-30	$529,235	15,001	-1.4%	Shares	Sole	2025-11-18
2025-06-30	$548,123	15,213	-73.2%	Shares	Sole	2025-08-19
2025-03-31	$1,765,475	56,713	+18.5%	Shares	Sole	2025-05-15
2024-12-31	$1,220,653	47,850	-8.4%	Shares	Sole	2025-02-13
2024-09-30	$1,477,275	52,219	0.0%	Shares	Sole	2024-11-14
2024-06-30	$1,377,015	52,219	+9158.7%	Shares	Sole	2024-08-13
2023-12-31	$15,842	564	+179.2%	Shares	Sole	2024-02-09
2023-03-31	$7,278	202	+0.5%	Shares	Sole	2023-05-17
2022-12-31	$7,943	201	—	Shares	Sole	2023-02-13
2020-12-31	$0	0	-100.0%	Shares	Sole	2021-02-09
2020-09-30	$21,035	500	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.